MRAI Stock Overview
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Marpai, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.13 |
| 52 Week High | US$3.46 |
| 52 Week Low | US$0.33 |
| Beta | 5.38 |
| 1 Month Change | -10.13% |
| 3 Month Change | 63.85% |
| 1 Year Change | -20.52% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -88.79% |
Recent News & Updates
Recent updates
Revenues Not Telling The Story For Marpai, Inc. (NASDAQ:MRAI) After Shares Rise 30%
Apr 07
Investors Still Aren't Entirely Convinced By Marpai, Inc.'s (NASDAQ:MRAI) Revenues Despite 34% Price Jump
Feb 16Market Might Still Lack Some Conviction On Marpai, Inc. (NASDAQ:MRAI) Even After 106% Share Price Boost
Dec 19Not Many Are Piling Into Marpai, Inc. (NASDAQ:MRAI) Stock Yet As It Plummets 28%
Jun 29Marpai rallies after directors buy shares
Aug 19Marpai to acquire Maestro Health for $22.1M
Aug 04Shareholder Returns
| MRAI | US Insurance | US Market | |
|---|---|---|---|
| 7D | -14.1% | 1.4% | 1.0% |
| 1Y | -20.5% | 25.1% | 21.9% |
Return vs Industry: MRAI underperformed the US Insurance industry which returned 27.9% over the past year.
Return vs Market: MRAI underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| MRAI volatility | |
|---|---|
| MRAI Average Weekly Movement | 20.7% |
| Insurance Industry Average Movement | 4.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MRAI's share price has been volatile over the past 3 months.
Volatility Over Time: MRAI's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 162 | Damien Lamendola | www.marpaihealth.com |
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology.
Marpai, Inc. Fundamentals Summary
| MRAI fundamental statistics | |
|---|---|
| Market cap | US$21.94m |
| Earnings (TTM) | -US$28.75m |
| Revenue (TTM) | US$37.16m |
0.6x
P/S Ratio-0.8x
P/E RatioIs MRAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRAI income statement (TTM) | |
|---|---|
| Revenue | US$37.16m |
| Cost of Revenue | US$24.24m |
| Gross Profit | US$12.92m |
| Other Expenses | US$41.67m |
| Earnings | -US$28.75m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.79 |
| Gross Margin | 34.76% |
| Net Profit Margin | -77.38% |
| Debt/Equity Ratio | -149.0% |
How did MRAI perform over the long term?
See historical performance and comparison